Five months after the first drug prices negotiated under the Inflation Reduction Act took effect, at least two drugmakers — Amgen and AbbVie — say they’re feeling the impact.
At least two drugmakers say they’re feeling the impact of the Inflation Reduction Act, after the first drug prices negotiated under the law took effect …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
FDA revisits a rare cancer treatment it rejected a few months ago
Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
UCB to acquire maker of antibody treatments for autoimmune diseases
Avalo shares spike on skin drug data; BioNTech to cut staff
Biotech M&A is accelerating. Track the deals that are happening here.
Astellas treatment offers new hope to a devastated rare disease community
Lilly, Gilead lead pharma’s M&A boom
